About Egetis

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment


A skilled and experienced organization

Egetis’ organization is small, but it is experienced and effective, has a knowledge-intensive network and has unique, integrated drug development expertise.

Substantial expertise in the entire drug development chain

A new management team was appointed in 2017 with the remit to establish the optimum conditions to further develop its drug candidates. The company’s in-house expertise has been reinforced, and this expertise is solid throughout the entire value chain, from clinical development to successful registration of drug candidates. The company’s employees have extensive collective experience in preclinical and clinical pharmaceutical drug development, strategic regulatory expertise (regulatory affairs with the FDA, EMA and PMDA), financing and investments (understanding of investors’ demands for a sustainable business), CMC (chemistry manufacturing and control of the active drug substance), planning and project management of clinical studies, purchasing, project management and cooperation with partners such as API (active pharmaceutical ingredient) manufacturers, CROs (contract research organizations) and patenting. Post the acquisition of Rare Thyroid Therapeutics in Q4 2020 (RTT) the company have core expertise in late-stage orphan drug development, registration, and commercialisation including the orphan drug segment.

In addition to expertise and experience, flexibility and good teamwork are needed to successfully carry out complex pharmaceutical drug development. The company’s employees are organized into cross-functional teams that enable a holistic view and greater opportunities to take the development projects all the way to the end.

The Company also engages consultants and partners when there is a need for specific expertise.

Egetis Therapeutics Corporate Values – “Triple C”

  • Courage – We challenge the status quo for the benefit of the patient
  • Commitment – We operate with high ethical standards through an efficient organization to deliver top quality results
  • Collaboration – Through trust, we work seamlessly across functions and with external partners



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com